In addition, a “correction” of ODC overexpression via treatment with indomethacin in colon cancer cells (HCT-116), which carry a mutation in the KRAS gene, was previously reported (Turchanowa et al., 2001). This evidence concerns the gene KRAS and malignant colon neoplasm.